v3.25.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 28, 2025
Equity [Abstract]  
Schedule of Allocation of Share-Based Compensation Expense
The following table sets forth the detailed allocation of the share-based compensation expense which was included in the Company’s condensed consolidated statements of operations:
 Three Months Ended
(in thousands)March 28, 2025March 29, 2024
Cost of revenue$562 $523 
Research and development2,492 1,955 
Selling, general and administrative5,411 4,445 
Total$8,465 $6,923 
Schedule of Restricted Stock Units
(in thousands, except per share amounts)Number
of
Shares
Weighted Average
Grant-Date Fair Value
Per Share
Balance at December 31, 20243,447 $12.95 
Granted1,148 8.77
Vested(1,372)12.32
Forfeited(83)13.11
Balance at March 28, 20253,140 $11.69